In last trading session, Guardant Health Inc (NASDAQ:GH) saw 5.66 million shares changing hands with its beta currently measuring 1.11. Company’s recent per share price level of $28.59 trading at $3.3 or 13.05% at ring of the bell on the day assigns it a market valuation of $3.52B. That closing price of GH’s stock is at a discount of -29.56% from its 52-week high price of $37.04 and is indicating a premium of 44.7% from its 52-week low price of $15.81. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 1.94 million shares which gives us an average trading volume of 2.13 million if we extend that period to 3-months.
For Guardant Health Inc (GH), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.38. Splitting up the data highlights that, out of 13 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 13 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.74 in the current quarter.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Guardant Health Inc (NASDAQ:GH) trade information
Upright in the green during last session for gaining 13.05%, in the last five days GH remained trading in the green while hitting it’s week-highest on Thursday, 11/07/24 when the stock touched $28.59 price level, adding 15.01% to its value on the day. Guardant Health Inc’s shares saw a change of 5.69% in year-to-date performance and have moved 30.67% in past 5-day. Guardant Health Inc (NASDAQ:GH) showed a performance of 36.86% in past 30-days. Number of shares sold short was 13.68 million shares which calculate 7.18 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 40 to the stock, which implies a rise of 28.52% to its current value. Analysts have been projecting 36 as a low price target for the stock while placing it at a high target of 125. It follows that stock’s current price would drop -25.92% in reaching the projected high whereas dropping to the targeted low would mean a loss of -25.92% for stock’s current value.
Guardant Health Inc (GH) estimates and forecasts
Statistics highlight that Guardant Health Inc is scoring comparatively higher than the scores of other players of the relevant industry. The company added 53.38% of value to its shares in past 6 months, showing an annual growth rate of 53.27% while that of industry is 16.60. Apart from that, the company came raising its revenue forecast for fiscal year 2024. This year revenue growth is estimated to rise 23.30% from the last financial year’s standing.
20 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 170.62M for the same. And 20 analysts are in estimates of company making revenue of 180.41M in the next quarter. Company posted 143.03M and 155.05M of sales in current and next quarters respectively a year earlier.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -8.88% during past 5 years. In 2024, company’s earnings growth rate is likely to be around 19.54% while estimates for its earnings growth in next 5 years are of 29.20%.
Guardant Health Inc (NASDAQ:GH)’s Major holders
Insiders are in possession of 4.58% of company’s total shares while institution are holding 100.16 percent of that, with stock having share float percentage of 104.97%. Investors also watch the number of corporate investors in a company very closely, which is 100.16% institutions for Guardant Health Inc that are currently holding shares of the company. VANGUARD GROUP INC is the top institutional holder at GH for having 11.64 million shares of worth $336.07 million. And as of 2024-06-30, it was holding 9.5609 of the company’s outstanding shares.
The second largest institutional holder is BLACKROCK INC., which was holding about 11.24 million shares on 2024-06-30. The number of shares represents firm’s hold over 9.2332 of outstanding shares, having a total worth of $324.55 million.
